Biosimilars are biologic medical products that are developed to be similar to an already approved biologic drug, known as the reference product. Biosimilars offer affordable alternatives to expensive biologic drugs with similar clinical benefits. They provide an opportunity to treat more patients with serious or life-threatening illnesses. Major players are investing heavily in research and development of biosimilars to capitalize on the patent expiry of blockbuster biologics and expand ... Read more
